FeesSafety
Pluang+

Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

18 Nov 2026, 23:00 WIB
Precedence Research
View Source
Bullish
Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

The global pharmaceutical market is projected to grow from $1.88 trillion in 2026 to $3.20 trillion by 2035, driven mainly by obesity and oncology drugs. The U.S. market, holding 42% of the global share, faces new tariffs linked to pricing deals and manufacturing commitments that reshape supply chains. Companies like Eli Lilly and AstraZeneca are seeing strong revenue growth from obesity and cancer treatments. Strategic focus is on pipeline renewal, U.S. manufacturing, and adapting to pricing policies, with biologics and generics also expanding rapidly.

As of Nov 18, 2026 23:13 WIB, Eli Lilly (LLY) shares trade at USD 1,387.45 with a 1-day decline of 1.99%, while AstraZeneca (AZN) is priced at USD 178.65, also down 1.99% on the day. Both companies, noted for their growth in obesity and oncology drugs, see strong investor interest on Pluang, with 76% of LLY orders and 65% of AZN orders being buy orders. Eli Lilly's market cap stands at $1.26 trillion, highlighting its significant role in the pharmaceutical sector.

More News (LLY)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App